Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/6/2024 | $223.00 | Neutral | BofA Securities |
| 10/16/2024 | $220.00 → $283.00 | Hold → Buy | TD Cowen |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 7/26/2024 | $162.00 → $219.00 | Underweight → Neutral | Cantor Fitzgerald |
| 7/26/2024 | $256.00 | Equal Weight → Overweight | Barclays |
| 6/26/2024 | $198.00 → $236.00 | Neutral → Outperform | Robert W. Baird |
| 5/30/2024 | $198.00 | Neutral | Robert W. Baird |
| 5/20/2024 | $189.00 → $226.00 | Neutral → Buy | UBS |
10-Q - UNIVERSAL HEALTH SERVICES INC (0000352915) (Filer)
8-K - UNIVERSAL HEALTH SERVICES INC (0000352915) (Filer)
8-K - UNIVERSAL HEALTH SERVICES INC (0000352915) (Filer)
4 - UNIVERSAL HEALTH SERVICES INC (0000352915) (Issuer)
4 - UNIVERSAL HEALTH SERVICES INC (0000352915) (Issuer)
4 - UNIVERSAL HEALTH SERVICES INC (0000352915) (Issuer)
Cantor Fitzgerald analyst Sarah James reiterates Universal Health Servs (NYSE:UHS) with a Underweight and maintains $162 price target.
BofA Securities resumed coverage of Universal Health with a rating of Neutral and set a new price target of $223.00
TD Cowen upgraded Universal Health from Hold to Buy and set a new price target of $283.00 from $220.00 previously
KeyBanc Capital Markets initiated coverage of Universal Health with a rating of Sector Weight
KING OF PRUSSIA, Pa., Oct. 25, 2022 /PRNewswire/ -- Universal Health Services, Inc. (NYSE:UHS) has announced the appointment of Edward (Eddie) H. Sim to Executive Vice President and President, Acute Care, succeeding Marvin Pember, who has announced his intention to retire. Reporting to President and CEO Marc D. Miller, Eddie will drive strategy and operations across the UHS Acute Care portfolio including UHS' Acute Care hospitals, freestanding emergency departments (FEDs) and ambulatory centers, as well as Independence Physician Management and Prominence Health Plan. "We thank Marvin for his service to UHS," said Marc D. Miller, President and CEO, UHS. "Under Marvin's leadership over the pas
KING OF PRUSSIA, Pa., Nov. 20, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE:UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.20 per share on December 17, 2024 to shareholders of record as of December 3, 2024. Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom. View original content:https://www.prnewswire.com/news-releases/universal-health-services-incann
KING OF PRUSSIA, Pa., Oct. 2, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its third quarter ended September 30, 2024, after the market closes on Thursday, October 24, 2024. There will be a conference call for investors and analysts at 9:00 a.m. Eastern Time on Friday, October 25, 2024. A live webcast of the call will be available on the company's website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended June 30, 2024 and 2023: KING OF PRUSSIA, Pa., July 24, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE:UHS) announced today that its reported net income attributable to UHS was $289.2 million, or $4.26 per diluted share, during the second quarter of 2024, as compared to $171.3 million, or $2.42 per diluted share, during the second quarter of 2023. Net revenues increased by 10.1% to $3.908 billion during the second quarter of 2024, as compared to $3.548 billion during the second quarter of 2023. As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), ou
SC 13G/A - UNIVERSAL HEALTH SERVICES INC (0000352915) (Subject)
SC 13G/A - UNIVERSAL HEALTH SERVICES INC (0000352915) (Subject)
SC 13G/A - UNIVERSAL HEALTH SERVICES INC (0000352915) (Subject)
KING OF PRUSSIA, Pa., Nov. 20, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE:UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.20 per share on December 17, 2024 to shareholders of record as of December 3, 2024. Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom. View original content:https://www.prnewswire.com/news-releases/universal-health-services-incann
KING OF PRUSSIA, Pa., Oct. 29, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE:UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the 2024 Wolfe Research Healthcare Conference in New York, New York on Tuesday, November 19, 2024 at 12:20PM (ET). A live audio webcast of the presentation will be available on the Company's website (www.uhsinc.com). For those unable to listen to the live webcast, replays of the presentation will be available on the Company's website for 90 days following the conference. Universal Health Services, Inc. is one of the nation's largest hospital companies, operating through its subsidiaries, acute c
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended September 30, 2024 and 2023: KING OF PRUSSIA, Penn., Oct. 24, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE:UHS) announced today that its reported net income attributable to UHS was $258.7 million, or $3.80 per diluted share, during the third quarter of 2024, as compared to $167.0 million, or $2.40 per diluted share, during the third quarter of 2023. Net revenues increased by 11.2% to $3.963 billion during the third quarter of 2024, as compared to $3.563 billion during the third quarter of 2023. As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"),